Search Within

Gopakumar Vasudeva Iyer

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (118)
  2. Journal Article (70)
  3. Correspondence (2)
  4. Editorial (2)
  5. Book Section (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (194)
  2. GSK Faculty (194)
  3. Genitourinary Oncology Service (194)
  4. Solid Tumor Oncology Division (194)
  5. Human Oncology and Pathogenesis Program (186)
  6. Department of Pathology and Laboratory Medicine (177)

More Groups

People
  1. David Solit (181)
  2. Hikmat Al-Ahmadie (152)
  3. Dean Bajorin (121)
  4. Jonathan Rosenberg (112)
  5. Bernard Bochner (110)
  6. Michael Berger (102)

More People

Years
  1. 2025 (4)
  2. 2024 (13)
  3. 2023 (10)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (54)
  2. Laboratory Investigation (27)
  3. Modern Pathology (20)
  4. Cancer Research (14)
  5. Clinical Cancer Research (12)
  6. European Urology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (61)
  2. Nature Publishing Group (39)
  3. American Association for Cancer Research (29)
  4. Nature Research (20)
  5. Elsevier Inc. (12)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (194)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Clinical, molecular and immunohistochemical profiles of clear cell adenocarcinoma of the urinary tract
    Meeting Abstract

    Koll, F.; Rammal, R.; Chen, Z.; Basar, M.; Alam, S. M.; Tallman, J. E.; Pietzak, E.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Carcinoma in situ and urinary cytology as an indicator of minimal residual disease in patients with non-muscle invasive bladder cancer treated with BCG
    Meeting Abstract

    Katims, A. B.; D'Souza, N.; De Jesus Escaño, M. R.; Gokturk, G.; Basar, M.; Solit, D. B.; Iyer, G.; Bochner, B. H.; Goh, A.; Donahue, T. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Comutational patterns in FGFR3-altered non-muscle invasive bladder cancer influence recurrence and progression
    Meeting Abstract

    D'Souza, N.; de Jesus Escano, M.; Alam, S. M.; Gao, S.; Tang, X.; Goh, A.; Bochner, B. H.; Solit, D.; Iyer, G.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save